For example, the prognostic significance of IDH mutations may be secondary to their prevalence among younger patients, as age is a well-known prognostic factor in gliomas.5 In AML, the prognostic significance of IDH mutations is more ambiguous. The gene discussed is IDH1; the disease is acute myeloid leukemia.